Ownership history in XTX Topco Ltd · 7 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ROYALTY PHARMA PLC (RPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 145,144 | +92,025 | +173.2% | 0.27% | $5.1M | $34.90 |
| 2025 Q1 | ADDED | 53,119 | +32,208 | +154.0% | 0.08% | $1.7M | $30.41 |
| 2023 Q2 | ADDED | 20,911 | +11,636 | +125.5% | 0.12% | $643K | $28.52 |
| 2023 Q1 | REDUCED | 9,275 | -2,971 | -24.3% | 0.07% | $334K | $33.23 |
| 2022 Q4 | ADDED | 12,246 | +6,049 | +97.6% | 0.10% | $484K | $36.25 |
| 2022 Q3 | REDUCED | 6,197 | -4,083 | -39.7% | 0.06% | $249K | $36.69 |
| 2021 Q4 | INITIATED | 10,280 | — | — | 0.23% | $410K | $35.90 |
As of 2025 Q4 — sorted by position size